Search results
Showing 16 to 30 of 125 results for thyroid* OR hypothyroid* OR Hyperthyroid* OR goiter
Evidence-based recommendations on vandetanib (Caprelsa) for treating medullary thyroid cancer in adults.
Evidence-based recommendations on cabozantinib (Cometriq) for treating medullary thyroid cancer in adults.
Selpercatinib for untreated RET-positive advanced thyroid cancer [ID6183]
In development [GID-TA11160] Expected publication date: TBC
Awaiting development [GID-TA11398] Expected publication date: 13 November 2024
In development [GID-TA11047] Expected publication date: 21 August 2024
Bipolar, schizophrenia and other psychoses: target organ damage (IND86)
This indicator covers the percentage of patients on lithium therapy with a record of serum creatinine and TSH in the preceding 9 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM21
effectiveness of dosimetry-guided radioactive iodine strategies for hyperthyroidism? Any explanatory notes(if applicable) Why the...
What is the clinical and cost effectiveness of iodine for people with subclinical hypothyroidism?
subclinical hypothyroidism? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism?
subclinical hypothyroidism? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
subclinical hypothyroidism? Any explanatory notes(if applicable) Source guidance details Comes from guidance Thyroid...
liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded...
for improving long-term health outcomes for people with subclinical hyperthyroidism? Any explanatory notes(if applicable) Why the...
and cost effectiveness, including safety, of radioactive iodine for hyperthyroidism? Any explanatory notes(if applicable) Why the...
This guideline covers diagnosing and managing myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) in children, young people and adults. It aims to improve awareness and understanding about ME/CFS and when to suspect it, so that people are diagnosed earlier. It includes recommendations on diagnosis, assessment and care planning, safeguarding, access to care and managing ME/CFS and its symptoms.
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)
This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS (COPD–OSAHS overlap syndrome) in people over 16. It aims to improve recognition, investigation and treatment of these related conditions.